Results 31 to 40 of about 4,434,840 (211)

Colorectal cysts as a validating tool for CAR therapy

open access: yesBMC Biotechnology, 2020
Background Treatment of cancers has largely benefited from the development of immunotherapy. In particular, Chimeric Antigen Receptor (CAR) redirected T cells have demonstrated impressive efficacy against B-cell malignancies and continuous efforts are ...
Pierre Dillard   +7 more
doaj   +1 more source

ASTCT Clinical Practice Recommendations for Transplantation and Cellular Therapies in Multiple Myeloma

open access: yes, 2022
Over the past decade, therapeutic options in multiple myeloma (MM) have changed dramatically. Given the unprecedented efficacy of novel agents, the role of hematopoietic cell transplantation (HCT) in MM remains under scrutiny.
Costa, Luciano   +74 more
core   +1 more source

Preliminary Report of the Academic CAR-T (ISIKOK-19) Cell Clinical Trial in Turkey: Characterization of Product and Outcomes of Clinical Application

open access: yesTurkish Journal of Hematology, 2022
Objective: Chimeric antigen receptor T (CAR-T) cell therapies have already made an impact on the treatment of B-cell malignancies. Although CAR-T cell therapies are promising, there are concerns about commercial products regarding their affordability and
Ebru Erdoğan   +23 more
doaj   +1 more source

ISBT 128 coding and labeling for cellular therapy products [PDF]

open access: yes, 2010
This paper describes the development of the ISBT 128 coding and labeling for cellular therapy products. It is published on behalf of the international Cellular Therapy Coding and Labeling Advisory Group (see www.ICCBBA ...
Ineke Slaper-Cortenbach   +3 more
core   +1 more source

Relapse after allogeneic stem cell transplantation of acute myeloid leukemia and myelodysplastic syndrome and importance of second cellular therapy

open access: yes, 2021
Patients with acute myelogenous leukemia (AML) or myelodysplastic syndrome (MDS) who relapse after allogeneic hematopoietic cell transplantation (allo-HCT) generally have poor overall survival (OS).
Goldberg AD   +65 more
core   +1 more source

Advancements in Veterinary Practice: Unleashing the Power of Cellular Therapy

open access: yes, 2023
Cellular therapy utilizes the regenerative potential of cells to aid in the treatment and healing of various ailments in animals. This article explores the concept of cellular therapy, its applications in veterinary medicine, and the evidence supporting ...
Amitha Banu S*, Sharun Khan, S.K Maiti, A. M. Pawde
core   +1 more source

High-throughput immunophenotypic characterization of bone marrow- and cord blood-derived mesenchymal stromal cells reveals common and differentially expressed markers: identification of angiotensin-converting enzyme (CD143) as a marker differentially expressed between adult and perinatal tissue sources

open access: yesStem Cell Research & Therapy, 2018
Background Mesenchymal stromal cells (MSC) are a heterogeneous population of multipotent progenitors used in the clinic because of their immunomodulatory properties and their ability to differentiate into multiple mesodermal lineages.
Eliana Amati   +8 more
doaj   +1 more source

Nutritional Status at Diagnosis and Pre-transplant Weight Loss Impact Outcomes of Acute Myeloid Leukemia Patients Following Allogeneic Stem Cell Transplantation

open access: yesHemaSphere, 2021
The nutritional status at diagnosis, as well as weight loss during chemotherapy, are important factors for morbidity and mortality in cancer patients. They might also influence outcomes in patients with acute myeloid leukemia (AML) receiving allogeneic ...
Dominic Brauer   +7 more
doaj   +1 more source

Gamma-irradiated SARS-CoV-2 vaccine candidate, OZG-38.61.3, confers protection from SARS-CoV-2 challenge in human ACEII-transgenic mice

open access: yesScientific Reports, 2021
The SARS-CoV-2 virus caused the most severe pandemic around the world, and vaccine development for urgent use became a crucial issue. Inactivated virus formulated vaccines such as Hepatitis A and smallpox proved to be reliable approaches for immunization
Raife Dilek Turan   +32 more
doaj   +1 more source

Allogeneic stem cell transplant for multiple myeloma & myelofibrosis with split-dose busulfan, fludarabine & cyclophosphamide

open access: yesLeukemia Research Reports, 2023
Allogeneic stem cell transplant can have high morbidity and mortality in patients with myelofibrosis (MF) and multiple myeloma (MM). This phase 2 study used a novel myeloablative regimen of split-dose busulfan, fludarabine, and then post-transplant ...
Andrew D. Trunk   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy